451 related articles for article (PubMed ID: 33743082)
1. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.
Gallieni M; De Salvo C; Lunati ME; Rossi A; D'Addio F; Pastore I; Sabiu G; Miglio R; Zuccotti GV; Fiorina P
Acta Diabetol; 2021 Aug; 58(8):975-981. PubMed ID: 33743082
[TBL] [Abstract][Full Text] [Related]
2. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
[TBL] [Abstract][Full Text] [Related]
4. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
[TBL] [Abstract][Full Text] [Related]
5. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
Ushigome E; Matsusaki S; Watanabe N; Hashimoto T; Nakamura N; Fukui M
J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596
[TBL] [Abstract][Full Text] [Related]
6. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
[TBL] [Abstract][Full Text] [Related]
7. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
Wada N; Mori K; Nakagawa C; Sawa J; Kumeda Y; Shoji T; Emoto M; Inaba M
J Diabetes Complications; 2015; 29(8):1310-3. PubMed ID: 26298521
[TBL] [Abstract][Full Text] [Related]
8. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T; Peng L; Umpierrez GE
Diabetes Care; 2024 Feb; 47(2):267-271. PubMed ID: 38085705
[TBL] [Abstract][Full Text] [Related]
10. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
[TBL] [Abstract][Full Text] [Related]
11. Influence of albumin leakage on glycated albumin in patients with type 2 diabetes undergoing hemodialysis.
Ueda S; Nagai K; Yokota N; Hirose D; Mori H; Noma Y; Doi T; Minakuchi J
J Artif Organs; 2019 Sep; 22(3):264-267. PubMed ID: 30805746
[TBL] [Abstract][Full Text] [Related]
12. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
[TBL] [Abstract][Full Text] [Related]
13. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
[TBL] [Abstract][Full Text] [Related]
14. Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis.
Meyer L; Chantrel F; Imhoff O; Sissoko A; Serb L; Dorey F; Fleury D; Smagala A; Kepenekian L; Krummel T; Le Floch JP; Kessler L
Diabet Med; 2013 Nov; 30(11):1388-9. PubMed ID: 23909880
[No Abstract] [Full Text] [Related]
15. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
[TBL] [Abstract][Full Text] [Related]
16. Glycated albumin in diabetic patients with chronic kidney disease.
Zheng CM; Ma WY; Wu CC; Lu KC
Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
[TBL] [Abstract][Full Text] [Related]
17. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
[TBL] [Abstract][Full Text] [Related]
18. Distinct biomarker roles for HbA
Hayashi A; Takano K; Masaki T; Yoshino S; Ogawa A; Shichiri M
J Diabetes Complications; 2016; 30(8):1494-1499. PubMed ID: 27614726
[TBL] [Abstract][Full Text] [Related]
19. How does CKD affect HbA1c?
Bloomgarden Z; Handelsman Y
J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
[TBL] [Abstract][Full Text] [Related]
20. Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.
Lee SY; Chen YC; Tsai IC; Yen CJ; Chueh SN; Chuang HF; Wu HY; Chiang CK; Cheng HT; Hung KY; Huang JW
PLoS One; 2013; 8(3):e57762. PubMed ID: 23469230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]